In HCC, there was a 3-fold reduction in DLC1 expression, while DLC2 and DLC3 expression was not reduced, in part because there was increased expression of DLC2 and, especially, DLC3 in a substantial number of the tumors (Figure 2C). The gene discussed is STARD13; the disease is hepatocellular carcinoma.